Results From the First Multicenter, Open-label, Phase IIIb Study Investigating the Combination of Pertuzumab With Subcutaneous Trastuzumab and a Taxane in Patients With HER2-positive Metastatic Breast Cancer (SAPPHIRE)
Woodward, Natasha, De Boer, Richard H., Redfern, Andrew, White, Michelle, Young, Jennifer, Truman, Matt, Beith, JaneJournal:
Clinical Breast Cancer
DOI:
10.1016/j.clbc.2019.02.008
Date:
February, 2019
File:
PDF, 630 KB
2019
File converter
More search results
More benefits 
